NK-1 RECEPTOR ANTAGONISTS FOR PREVENTION OF NEUROGENIC INFLAMMATION IN GENE THERAPY
摘要
The present invention relates to a method of preventing or treating the neurogenic inflammation associated with the use of viral vectors in gene therapy in a mammal, including a human, by administering to the mammal an NK-1 receptor antagonist (e.g., a substance P receptor antagonist).
申请公布号
WO9713514(A1)
申请公布日期
1997.04.17
申请号
WO1996IB01042
申请日期
1996.10.02
申请人
PFIZER INC.;PIEDIMONTE, GIOVANNI;HESS, HANS, J.;LOWE, JOHN, A., III
发明人
PIEDIMONTE, GIOVANNI;HESS, HANS, J.;LOWE, JOHN, A., III
